
Y.S.P. Industries (M) Sdn. Bhd.
Y.S.P. SOUTHEAST ASIA HOLDING BHD. 200101017024 (552781-X) Notice under Personal Data Protection Act: HOME: ABOUT US: INVESTOR: MARKETING INFORMATION: …
Investor - yspsah.com
At , our strength lies in our unwavering commitment in harnessing the best of our resources, both manpower and technology. In fact, we have made a thrust in the global marketplace through …
Yungshingroup - Y.S.P. Southeast Asia Holding Berhad
Today the Group boasts a wide array of pharmaceutical, over-the-counter (OTC), veterinary and aquatic products, with regional offices as well as strategic alliances in Singapore, Vietnam, …
Branch Offices In Malaysia - yspsah.com
To satisfy market demand instantly, we have built a 5,400 square meter logistics centre which complies with GMP and GSP regulations. With our ERP information system and computer …
永信國際投資控股 - 永信東南亞控股有限公司
y.s.p. southeast asia holding berhad(y.s.p. sah)為根據1965年公司法令,於2001年7月在馬來西亞這冊成立之投資控股公司,其子公司主要從事進口、出口、貿易及生產人用藥物、動物藥物 …
YSP Southeast Asia Holding Bhd (YSPSAH) Stock Price & News
Get the latest YSP Southeast Asia Holding Bhd (YSPSAH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading …
Yungshingroup - YungShin Industries (Malaysia) Sdn Bhd
With research-based production, at YSP Malaysia we produce quality tablets, capsules, suppositories, and ointments. The products we carry include OTC, animal and aquacultural …
YSPSAH: Y.S.P. SOUTHEAST ASIA HOLDING BERHAD (7178)
2003年9月30日 · Pharmaceutical company YSP Southeast Asia Holding Bhd (KL:YSPSAH)’s net profit fell 41.9% to RM3.47 million in the third quarter ended Sept 30, 2024 (3QFY2024), from …
Y.S.P.SOUTHEAST ASIA HOLDING BERHAD (7178) - Bursa Malaysia
2025年3月21日 · 22 Apr 2024 First and Final Dividend. EX-date: 24 Jun 2024. Entitlement date: 25 Jun 2024. Entitlement description: Final Single-tier Ordinary Dividend of 8.0 sen per …
YSPSAH (7178) Overview - Y.S.P.SOUTHEAST ASIA HOLDING
Y SP Southeast Asia Holding Bhd is an investment company, which engages in the pharmaceutical business, provision of management services. It operates through the following …